Tiny RNA with great effects: miR-155 in alcoholic liver disease (Englisch)
- Neue Suche nach: Hartmann, P.
- Neue Suche nach: Tacke, F.
- Neue Suche nach: Hartmann, P.
- Neue Suche nach: Tacke, F.
In:
JOURNAL OF HEPATOLOGY
;
64
, 6
;
1214-1216
;
2016
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Tiny RNA with great effects: miR-155 in alcoholic liver disease
-
Beteiligte:Hartmann, P. ( Autor:in ) / Tacke, F. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 64, 6 ; 1214-1216
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2016
-
Format / Umfang:3 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 64, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1199
-
From the Editor’s desk...Moreau, R. / Bataller, R. / Berg, T. / Zucman-Rossi, J. / Jalan, R. et al. | 2016
- 1203
-
Not all mice are the same: Standardization of animal research data presentation| 2016
- 1206
-
Direct acting antivirals for decompensated cirrhosis. Efficacy and safety are now establishedCurry, M. P. et al. | 2016
- 1208
-
T cell fitness in the liver: How can T cells keep it up?Bertoletti, A. et al. | 2016
- 1211
-
Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetesWong, V. W. / Chalasani, N. et al. | 2016
- 1214
-
Tiny RNA with great effects: miR-155 in alcoholic liver diseaseHartmann, P. / Tacke, F. et al. | 2016
- 1217
-
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general populationBruno, S. / Di Marco, V. / Iavarone, M. / Roffi, L. / Crosignani, A. / Calvaruso, V. / Aghemo, A. / Cabibbo, G. / Viganò, M. / Boccaccio, V. et al. | 2016
- 1224
-
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosisFoster, G. R. / Irving, W. L. / Cheung, M. C. / Walker, A. J. / Hudson, B. E. / Verma, S. / McLauchlan, J. / Mutimer, D. J. / Brown, A. / Gelson, W. T. et al. | 2016
- 1232
-
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvirDahari, H. / Canini, L. / Graw, F. / Uprichard, S. L. / Araújo, E. S. / Penaranda, G. / Coquet, E. / Chiche, L. / Riso, A. / Renou, C. et al. | 2016
- 1240
-
Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural EgyptMostafa, A. / Shimakawa, Y. / Medhat, A. / Mikhail, N. N. / Chesnais, C. d. / Arafa, N. / Bakr, I. / El Hoseiny, M. / El-Daly, M. / Esmat, G. et al. | 2016
- 1247
-
Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, CanadaJacka, B. / Applegate, T. / Poon, A. F. / Raghwani, J. / Harrigan, P. R. / DeBeck, K. / Milloy, M. J. / Krajden, M. / Olmstead, A. / Joy, J. B. et al. | 2016
- 1256
-
Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinomaChiu, Y. T. / Wong, J. K. / Choi, S. W. / Sze, K. M. / Ho, D. W. / Chan, L. K. / Lee, J. M. / Man, K. / Cherny, S. / Yang, W. L. et al. | 2016
- 1265
-
Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patientsTrebicka, J. / von Heydebrand, M. / Lehmann, J. / Tofteng, F. / Busk, T. / Jensen, H. L. / Rohde, J. / Reiberger, T. / Mortensen, C. / Schierwagen, R. et al. | 2016
- 1274
-
Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interactionShi, X. L. / Mancham, S. / Hansen, B. E. / de Knegt, R. J. / de Jonge, J. / van der Laan, L. J. / Rivadeneira, F. / Metselaar, H. J. / Kwekkeboom, J. et al. | 2016
- 1283
-
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axisWang, X. / Sun, W. / Shen, W. / Xia, M. / Chen, C. / Xiang, D. / Ning, B. / Cui, X. / Li, H. / Li, X. et al. | 2016
- 1295
-
miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growthHan, Y. / Meng, F. / Venter, J. / Wu, N. / Wan, Y. / Standeford, H. / Francis, H. / Meininger, C. / Greene, J. / Trzeciakowski, J. P. et al. | 2016
- 1305
-
The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8+ T cell activationEsser-Nobis, K. / Schmidt, J. / Nitschke, K. / Neumann-Haefelin, C. / Thimme, R. / Lohmann, V. et al. | 2016
- 1315
-
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytesTouboul, T. / Chen, S. / To, C. C. / Mora-Castilla, S. / Sabatini, K. / Tukey, R. H. / Laurent, L. C. et al. | 2016
- 1327
-
Effector T cell function rather than survival determines extent and duration of hepatitis in miceVo, M. / Holz, L. E. / Wong, Y. C. / English, K. / Benseler, V. / McGuffog, C. / Azuma, M. / McCaughan, G. W. / Bowen, D. G. / Bertolino, P. et al. | 2016
- 1339
-
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasisvan der Woerd, W. L. / Wichers, C. G. / Vestergaard, A. L. / Andersen, J. P. / Paulusma, C. C. / Houwen, R. H. / van de Graaf, S. F. et al. | 2016
- 1348
-
Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytesYovchev, M. I. / Locker, J. / Oertel, M. et al. | 2016
- 1358
-
Type 2 diabetes and risk of hospital admission or death for chronic liver diseasesWild, S. H. / Morling, J. R. / McAllister, D. A. / Kerssens, J. / Fischbacher, C. / Parkes, J. / Roderick, P. J. / Sattar, N. / Byrne, C. D. et al. | 2016
- 1365
-
Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosisXiang, M. / Wang, P. X. / Wang, A. B. / Zhang, X. J. / Zhang, Y. / Zhang, P. / Mei, F. H. / Chen, M. H. / Li, H. et al. | 2016
- 1378
-
The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitisBala, S. / Csak, T. / Saha, B. / Zatsiorsky, J. / Kodys, K. / Catalano, D. / Satishchandran, A. / Szabo, G. et al. | 2016
- 1388
-
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease| 2016
- 1403
-
IL-6 pathway in the liver: From physiopathology to therapySchmidt-Arras, D. / Rose-John, S. et al. | 2016
- 1416
-
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodellingBottazzi, B. / Inforzato, A. / Messa, M. / Barbagallo, M. / Magrini, E. / Garlanda, C. / Mantovani, A. et al. | 2016
- 1428
-
Clinical Trial Watch: Reports from the Liver Meeting®, AASLD, San Francisco, November 2015Wiegand, J. / van Bömmel, F. / Duarte-Rojo, A. s. / Altamirano, J. / Abraldes, J. G. / Villanueva, A. / Berg, T. et al. | 2016
- 1446
-
Rhesus macaques persistently infected with hepatitis E shed virus into urineHuang, F. / Yang, C. / Zhou, X. / Yu, W. / Pan, Q. et al. | 2016
- 1448
-
Reply to “Rhesus macaques persistently infected with hepatitis E shed virus into urine”Geng, Y. / Zhao, C. / Wang, Y. et al. | 2016
- 1449
-
Hepatocellular carcinoma scoring and staging systems. Do we need new tools?Adhoute, X. / Penaranda, G. / Raoul, J. L. / Bourlière, M. et al. | 2016
- 1450
-
Reply to “Hepatocellular carcinoma scoring and staging systems. Do we need new tools?”Liu, P. H. / Huo, T. I. et al. | 2016
- 1452
-
Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP)Bucsics, T. / Schwabl, P. / Mandorfer, M. / Peck-Radosavljevic, M. et al. | 2016
- 1454
-
Reply to “Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis”Alexopoulou, A. / Vasilieva, L. / Agiasotelli, D. / Dourakis, S. P. et al. | 2016
- 1455
-
Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers mattersMadsen, B. r. / Nielsen, K. F. / Fialla, A. D. / Krag, A. et al. | 2016
- 1456
-
Reply to “Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers matters”Jalan, R. / Mookerjee, R. P. / Pavesi, M. / Arroyo, V. et al. | 2016
- 1457
-
Further considerations in autoimmune hepatitisOzaslan, E. / Efe, C. et al. | 2016
- 1458
-
Reply to “Further considerations in autoimmune hepatitis”Lohse, A. W. / Chazouilleres, O. / Dalekos, G. / Drenth, J. P. / Heneghan, M. / Hofer, H. / Lammert, F. / Lenzi, M. et al. | 2016
- 1460
-
Corrigendum to “Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy” [J Hepatol 2011;54:195–200]Fung, J. / Seto, W. K. / Lai, C. L. / Yuen, J. / Wong, D. K. / Yuen, M. F. et al. | 2016
- 1461
-
Corrigendum to “Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma” [J Hepatol 2015;62:607–616]Yeung, O. W. / Lo, C. M. / Ling, C. C. / Qi, X. / Geng, W. / Li, C. X. / Ng, K. T. / Forbes, S. J. / Guan, X. Y. / Poon, R. T. et al. | 2016
- 1462
-
Erratum to “Clinical implications of basic research in hepatocellular carcinoma” [J Hepatol 2016;64:736–745]Dhanasekaran, R. / Venkatesh, S. K. / Torbenson, M. S. / Roberts, L. R. et al. | 2016
- i
-
Editorial Board| 2016
- x
-
The International Liver Congress. Amsterdam, The Netherlands. 2017| 2016
- xi
-
EASL Physician Scientist Fellowship Programme| 2016
- xii
-
EASL Special Conference: New perspectives in hepatitis C virus infection. Paris, France. 2016| 2016
- xiii
-
EASL Clinical School: Unmet needs in Hepatology. Paris, France. 2016| 2016
- xv
-
Contents| 2016
- xviii
-
EASL Masterclass 2016. Frankfurt, Germany. 2016| 2016